We achieved 100% specificity of this analysis, as MDM2 amplification was not detected in plasma specimens of 11 patients with other tumor types that are considered in differential diagnosis of WDLPS/DDLPS (median Z-score of -0.2, range: -5.7 to 1.3). The gene discussed is MDM2; the disease is neoplasm.